FLT4(VEGFR-3) as a target for tumor imaging and anti-tumor therapy

Details for Australian Patent Application No. 2002248372 (hide)

Owner Ludwig Institute for Cancer Research Licentia, Ltd.

Inventors Kaipainen, Arja; Korhonen, Jaana; Armstrong, Elina; Alitalo, Kari; Pajusola, Katri; Aprelikova, Olga

Agent Griffith Hack

Pub. Number AU-B-2002248372

PCT Pub. Number WO2002/060950

Priority 09/765,534 19.01.01 US

Filing date 22 January 2002

Wipo publication date 12 August 2002

Acceptance publication date 23 August 2007

International Classifications

C07K 14/71 (2006.01) Peptides having more than 20 amino acids

A61P 35/00 (2006.01) Antineoplastic agents

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

20 February 2003 Application Open to Public Inspection

  Published as AU-B-2002248372

23 August 2007 Application Accepted

  Published as AU-B-2002248372

20 December 2007 Standard Patent Sealed

7 August 2008 Assignment Registered

  Ludwig Institute for Cancer Research; Licentia Ltd The patent has been assigned to Vegenics Limited

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002248373-Metabolic controlled fermentation process for carbamoyl tobramycin production

2002248371-SYSTEM AND METHOD FOR WORLD WIDE WEB BASED MAPPING OF MULTIPLE SYSTEM NAME SPACES